title: Both pimecrolimus and corticosteroids deplete plasmacytoid dendritic cells in patients with atopic dermatitis.
authors.forename: Wolfram
authors.initials: W
authors.lastname: Hoetzenecker
authors.forename: Simone
authors.initials: S
authors.lastname: Meindl
authors.forename: Anton
authors.initials: A
authors.lastname: Stuetz
authors.forename: Georg
authors.initials: G
authors.lastname: Stingl
authors.forename: Adelheid
authors.initials: A
authors.lastname: Elbe-Bürger
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D003713:Dendritic Cells / Q000187:drug effects* / Q000473:pathology; D003876:Dermatitis, Atopic / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D003879:Dermatologic Agents / Q000627:therapeutic use*; D006801:Humans; D016559:Tacrolimus / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000305:Adrenal Cortex Hormones; D003879:Dermatologic Agents; C117268:pimecrolimus; D016559:Tacrolimus